| P2093 | author name string | Eric Prommer | |
| P2860 | cites work | Delirium: optimising management | Q24524866 |
| | alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role | Q28142296 |
| | The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects | Q28205334 |
| | Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists | Q28250766 |
| | Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects | Q28279789 |
| | Dexmedetomidine in anaesthesia | Q28301772 |
| | Human brain imidazoline receptors: further characterization with [3H]clonidine | Q48207505 |
| | Dexmedetomidine inhibits muscarinic type 3 receptors expressed in Xenopus oocytes and muscarine-induced intracellular Ca2+ elevation in cultured rat dorsal root ganglia cells | Q48591454 |
| | The use of dexmedetomidine in pediatric cardiac surgery | Q48689528 |
| | Dexmedetomidine related cardiac arrest in a patient with permanent pacemaker; a cautionary tale. | Q50925247 |
| | Pharmacokinetics and pharmacodynamics of transdermal dexmedetomidine. | Q51646185 |
| | The antinociceptive actions of dexmedetomidine on dorsal horn neuronal responses in the anaesthetized rat | Q51692496 |
| | Spinal Antinociception by Dexmedetomidine, a Highly Selective α2-Adrenergic Agonist | Q51717737 |
| | Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. | Q52028622 |
| | Diagnosis and management of delirium near the end of life | Q34297691 |
| | New agents for sedation in the intensive care unit | Q34474040 |
| | Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice. | Q35048705 |
| | Delirium in advanced cancer patients | Q35805731 |
| | Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients | Q36108269 |
| | The use of dexmedetomidine to facilitate acute discontinuation of opioids after cardiac transplantation in children. | Q36251652 |
| | Effect of alpha1-adrenergic receptors in cardiac pathophysiology | Q36636928 |
| | Dexmedetomidine: an updated review | Q36735205 |
| | Dexmedetomidine and ST-91 analgesia in the formalin model is mediated by alpha2A-adrenoceptors: a mechanism of action distinct from morphine | Q37002353 |
| | A new dosing protocol reduces dexmedetomidine-associated hypotension in critically ill surgical patients. | Q37050222 |
| | Dexmedetomidine: a review of clinical applications | Q37228095 |
| | Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial | Q37279801 |
| | Palliating delirium in patients with cancer | Q37382797 |
| | Treating agitation with dexmedetomidine in the ICU. | Q37456032 |
| | Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial | Q38383872 |
| | Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial | Q38393318 |
| | In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action | Q39927968 |
| | A double-blind, crossover assessment of the sedative and analgesic effects of intranasal dexmedetomidine | Q40190780 |
| | Protection of focal ischemic infarction by rilmenidine in the animal: evidence that interactions with central imidazoline receptors may be neuroprotective | Q40653987 |
| | Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms | Q42035990 |
| | Bioavailability of dexmedetomidine after extravascular doses in healthy subjects | Q42760132 |
| | The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment | Q43781326 |
| | Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions | Q43905326 |
| | Effect of antisense knock-down of alpha(2a)- and alpha(2c)-adrenoceptors on the antinociceptive action of clonidine on trigeminal nociception in the rat. | Q44050815 |
| | Meperidine exerts agonist activity at the alpha(2B)-adrenoceptor subtype | Q44096133 |
| | Learning and memory in agmatine-treated rats | Q44099934 |
| | Dexmedetomidine to facilitate drug withdrawal | Q44293057 |
| | A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit | Q44320906 |
| | The antinociceptive effects of intravenous dexmedetomidine in colorectal distension-induced visceral pain in rats: the role of opioid receptors | Q44343480 |
| | The use of dexmedetomidine to facilitate opioid and benzodiazepine detoxification in an infant | Q44345532 |
| | Dexmedetomidine infusion for sedation during fiberoptic intubation: a report of three cases | Q44863277 |
| | Comparative analgesic and mental effects of increasing plasma concentrations of dexmedetomidine and alfentanil in humans | Q45030653 |
| | Dexmedetomidine as a total intravenous anesthetic agent | Q45030659 |
| | Dexmedetomidine pharmacodynamics: Part II: Crossover comparison of the analgesic effect of dexmedetomidine and remifentanil in healthy volunteers | Q45124955 |
| | Cardiac arrest, a preventable yet a possible risk of dexmedetomidine: fact or fiction? | Q45163496 |
| | Central α2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidine | Q46124863 |
| | Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia. | Q46262412 |
| | Effect of intra-articular dexmedetomidine on postoperative analgesia after arthroscopic knee surgery | Q46528953 |
| | Sole use of dexmedetomidine has limited utility for conscious sedation during outpatient colonoscopy | Q46624801 |
| | Pharmacokinetics of intravenous dexmedetomidine in children under 11 yr of age. | Q46672587 |
| | A prospective, double-blind, randomized, placebo-controlled study of dexmedetomidine as an adjunct to epidural analgesia after thoracic surgery | Q46734402 |
| | Alpha2-adrenoceptor antagonists enhance responses of dorsal horn neurones to formalin induced inflammation | Q47882652 |
| P433 | issue | 4 | |
| P921 | main subject | dexmedetomidine | Q412133 |
| | review article | Q7318358 |
| P304 | page(s) | 276-283 | |
| P577 | publication date | 2010-12-03 | |
| P1433 | published in | American Journal of Hospice and Palliative Medicine | Q4744247 |
| P1476 | title | Review article: dexmedetomidine: does it have potential in palliative medicine? | |
| P478 | volume | 28 | |